Company Overview
Snapshot
Founded in October 2021 by Avi Motova and Dr shlomi isrelit, CatAI operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its AI-enhanced personal health care monitoring solutions.
Business overview
CatAI specializes in Health Tech & Life Sciences, offering an AI-enhanced remote patient monitoring solution designed for hospitals, clinics, nursing homes, and assisted living facilities. The company's core technology leverages AI and machine learning to capture vital signs via devices like tablets or smartphones, processing and sending data to healthcare providers for continuous monitoring. Additionally, CatAI has developed ORALYZE, a system that uses mobile phone imaging for the early detection of oral cancer, serving cancer centers, clinics, and insurance companies.
Log in to access full profile ›Company Intelligence Q&A
- What is CatAI's primary offering for healthcare providers?
- CatAI provides a remote patient monitoring (RPM) solution that allows hospitals, home care companies, and elderly care facilities to track medical parameters. The AI platform captures vital signs via mobile devices and sends data to healthcare providers' dashboards for continuous monitoring.
- What is the ORALYZE system?
- ORALYZE is CatAI's system for the early detection of oral cancer, utilizing mobile phone imaging. Research on this system, conducted in collaboration with the North of Israel Hospital, the Israeli Ministry of Health, and IBM, was published in the journal Cancers.
- What is CatAI's business model?
- CatAI employs B2G, B2B2C, and B2B business models, targeting government entities, businesses, and consumers through partnerships.
- When was CatAI founded?
- CatAI was founded in October 2021.
- Who are the founders of CatAI?
- CatAI was founded by Avi Motova and Dr shlomi isrelit.